|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01877 JUNSHI BIO
Nominal 
18.220 +0.110 (+0.607%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (514,514) | (1,442,841) | (2,014,964) | (1,775,325) |
| Net Cash from / (used in) Investing Activities | -- | (1,588,419) | (877,474) | (892,422) | (467,619) |
| Net Cash from / (used in) Financing Activities | -- | 2,231,960 | 1,016,837 | 681,041 | 4,643,009 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 129,027 | (1,303,478) | (2,226,345) | 2,400,065 |
| Cash & Cash Equivalents at beginning of period | -- | 2,486,679 | 3,778,142 | 5,996,936 | 3,504,605 |
| Effect of Foreign Exchange Rate Changes | -- | (21,706) | 12,015 | 7,551 | 92,266 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 2,594,000 | 2,486,679 | 3,778,142 | 5,996,936 |
| Remarks: | Real time quote last updated: 04/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 25,501 |
| %Change | -- |
| EPS / (LPS) | RMB 0.020 |
| NBV Per Share (¥) | RMB 5.809 |